rs 67333 has been researched along with Disease Models, Animal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Baranger, K; Bockaert, J; Claeysen, S; Gaven, F; Giannoni, P; Girard, SD; Girot, S; Khrestchatisky, M; Marchetti-Gauthier, E; Migliorati, M; Rivera, S; Roman, FS; Stephan, D | 1 |
| Darcet, F; David, DJ; Gardier, AM; Hen, R; Kerdine-Römer, S; Mendez-David, I; Wu, MV | 1 |
| Khodayar, E; Nasehi, M; Oryan, S; Zarrindast, MR | 1 |
| Abboussi, O; El Ganouni, S; Fifel, K; Lakehayli, S; Said, N; Tazi, A | 1 |
| Cho, S; Hu, Y | 1 |
| Bisgaard, C; Debonnel, G; Du, J; Haddjeri, N; Lambas-Senas, L; Lucas, G; Manta, S; Mnie-Filali, O; Piñeyro, G; Rymar, VV; Sadikot, AF; Wiborg, O | 1 |
7 other study(ies) available for rs 67333 and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Chronic treatments with a 5-HT
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Behavior, Animal; Disease Models, Animal; Encephalitis; Entorhinal Cortex; Learning; Male; Memory; Mice, Transgenic; Neuroglia; Piperidines; Plaque, Amyloid; Serotonin 5-HT4 Receptor Agonists | 2017 |
Rapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanism.
Topics: Aniline Compounds; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Comorbidity; Corticosterone; Depressive Disorder; Disease Models, Animal; Fluoxetine; Hippocampus; Indoles; Male; Mice; Mice, Inbred C57BL; Neurogenesis; Neurons; Piperidines; Receptors, Serotonin, 5-HT4; Serotonin 5-HT4 Receptor Agonists; Serotonin 5-HT4 Receptor Antagonists; Sulfonamides; Time Factors | 2014 |
Effect of nucleus accumbens shell 5-HT4 receptors on the impairment of ACPA-induced emotional memory consolidation in male Wistar rats.
Topics: Aniline Compounds; Animals; Arachidonic Acids; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Emotions; Male; Maze Learning; Memory Consolidation; Memory Disorders; Motor Activity; Nootropic Agents; Nucleus Accumbens; Piperidines; Pyrazoles; Random Allocation; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Serotonin, 5-HT4; Serotonin 5-HT4 Receptor Agonists | 2016 |
Behavioral effects of D3 receptor inhibition and 5-HT4 receptor activation on animals undergoing chronic cannabinoid exposure during adolescence.
Topics: Aging; Aniline Compounds; Animals; Anxiety; Behavior, Animal; Cannabinoids; Disease Models, Animal; Dopaminergic Neurons; Indans; Male; Memory; Morpholines; Piperidines; Rats, Wistar; Receptors, Dopamine D3; Receptors, Serotonin, 5-HT4; Schizophrenia; Serotonin 5-HT4 Receptor Antagonists | 2016 |
Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Male; Mice; Mice, Transgenic; Nerve Degeneration; Neurons; Neuroprotective Agents; Peptide Fragments; Piperidines; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Agonists; Serotonin Receptor Agonists; Synaptic Transmission; Treatment Outcome | 2007 |
Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.
Topics: Aniline Compounds; Animals; Antidepressive Agents; Brain; Cyclic AMP Response Element-Binding Protein; Depressive Disorder; Disease Models, Animal; Hippocampus; Male; Motor Activity; Phosphorylation; Piperidines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT4; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT4 Receptor Agonists; Serotonin Receptor Agonists; Stress, Psychological; Time Factors | 2007 |